4.0 Article

Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage

Sonia Ciudad et al.

NATURE COMMUNICATIONS (2020)

Article Clinical Neurology

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

Suzanne E. Schindler et al.

NEUROLOGY (2019)

Article Multidisciplinary Sciences

A vicious cycle of β amyloid-dependent neuronal hyperactivation

Benedikt Zott et al.

SCIENCE (2019)

Review Clinical Neurology

A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease

Francesco Panza et al.

NATURE REVIEWS NEUROLOGY (2019)

Review Clinical Neurology

Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies

Juan Carlos Polanco et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Chemistry, Analytical

Direct Evidence of the Presence of Cross-Linked Aβ Dimers in the Brains of Alzheimer's Disease Patients

Aurelio Vazquez de la Torre et al.

ANALYTICAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

A beta truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition

Erwin Cabrera et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Review Neurosciences

Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise

Christopher H. van Dyck

BIOLOGICAL PSYCHIATRY (2018)

Article Multidisciplinary Sciences

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Akinori Nakamura et al.

NATURE (2018)

Article Multidisciplinary Sciences

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

Joseph W. Arndt et al.

SCIENTIFIC REPORTS (2018)

Article Multidisciplinary Sciences

Amyloid-β with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation

O. G. Zatsepina et al.

SCIENTIFIC REPORTS (2018)

Article Multidisciplinary Sciences

Molecular subtypes of Alzheimer's disease

Giuseppe Di Fede et al.

SCIENTIFIC REPORTS (2018)

Review Biochemistry & Molecular Biology

APP/Aβ structural diversity and Alzheimer's disease pathogenesis

Alex E. Roher et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Clinical Neurology

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Susanne Ostrowitzki et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Article Multidisciplinary Sciences

Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain

Norelle C. Wildburger et al.

SCIENTIFIC REPORTS (2017)

Article Chemistry, Analytical

Fast and Effective Ion Mobility-Mass Spectrometry Separation of D-Amino-Acid-Containing Peptides

Kevin Jeanne Dit Fouque et al.

ANALYTICAL CHEMISTRY (2017)

Review Clinical Neurology

Emerging concepts in sporadic cerebral amyloid angiopathy

Andreas Charidimou et al.

Article Clinical Neurology

Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease

Keith A. Vossel et al.

ANNALS OF NEUROLOGY (2016)

Article Multidisciplinary Sciences

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Jeff Sevigny et al.

NATURE (2016)

Review Biochemistry & Molecular Biology

Old Proteins in Man: A Field its Infancy

Roger J. W. Truscott et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Clinical Neurology

Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials

Rik Vandenberghe et al.

ALZHEIMERS RESEARCH & THERAPY (2016)

Article Clinical Neurology

Age and amyloid effects on human central nervous system amyloid-beta kinetics

Bruce W. Patterson et al.

ANNALS OF NEUROLOGY (2015)

Article Medicine, General & Internal

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Clinical Neurology

Truncated and modified amyloid-beta species

Markus P. Kummer et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Neurosciences

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer's Disease Immunotherapy

Roxanna Perez-Garmendia et al.

CURRENT NEUROPHARMACOLOGY (2013)

Article Chemistry, Analytical

Differentiating N-Terminal Aspartic and Isoaspartic Acid Residues in Peptides

Nadezda P. Sargaeva et al.

ANALYTICAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

Kwasi G. Mawuenyega et al.

SCIENCE (2010)

Article Multidisciplinary Sciences

Molecular basis for passive immunotherapy of Alzheimer's disease

Anna S. Gardberg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Medical Laboratory Technology

Biochemistry of amino acid racemization and clinical application to musculoskeletal disease

Christopher R. McCudden et al.

CLINICAL BIOCHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Randall J. Bateman et al.

NATURE MEDICINE (2006)

Article Clinical Neurology

Incidence and predictors of seizures in patients with Alzheimer's disease

JC Amatniek et al.

EPILEPSIA (2006)

Article Multidisciplinary Sciences

A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR

AT Petkova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Biochemistry & Molecular Biology

Analysis of isoaspartate in peptides by electrospray tandem mass spectrometry

WD Lehmann et al.

PROTEIN SCIENCE (2000)

Article Biochemistry & Molecular Biology

Isoaspartate formation and neurodegeneration in Alzheimer's disease

T Shimizu et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)